Improving endothelial cell adhesion to vascular graft surfaces: clinical need and strategies.
Bhat, V D; Klitzman, B; Koger, K; Truskey, G A; Reichert, W M.
J Biomater Sci Polym Ed
; 9(11): 1117-35, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-9860176
Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular system.
Prostacyclin protects vascular integrity via PPAR/14-3-3 pathway.
Venous blood flow through vein grafts before harvesting minimizes endothelial cell desquamation immediately after implantation.
Engineered endothelial progenitor cells that overexpress prostacyclin protect vascular cells.
Use of a fibroblastic matrix improves the results of mesothelial-cell seeding on vascular prostheses of polytetrafluoroethylene.
Prostacyclin synthesis and prostacyclin receptor expression in the porcine corpus luteum: evidence for a luteotropic role in vitro.
Double-label expression studies of prostacyclin synthase, thromboxane synthase and COX isoforms in normal aortic endothelium.
Prostaglandin I2 Signaling and Inhibition of Group 2 Innate Lymphoid Cell Responses.
Endothelial progenitor cells bind and inhibit platelet function and thrombus formation.
Endothelium-derived prostaglandin I(2) controls the migration of eosinophils.